SCHEMBL2764359

SCHEMBL2764359

COc1cc(-c2nc(C=O)cs2)cc(OC)c1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.60
ALDH1A1 P00352 6/20 0.58
ERN1 O75460 1/20 0.44
HDAC3 O15379 5/20 0.43
HDAC1 Q13547 5/20 0.43
HDAC7 Q8WUI4 5/20 0.43
HDAC8 Q9BY41 5/20 0.43
HDAC6 Q9UBN7 5/20 0.43
EGFR P00533 2/20 0.42
HTR2B P41595 1/20 0.41
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3602067 0.84 MAPT (0.67) MAPTALDH1A1ERN1KDM4EHPGD
SCHEMBL5532236 0.81 ALDH1A1 (0.74) MAPTALDH1A1HTR2BKDM4EHPGD
SCHEMBL11263632 0.78 ACHE (0.44) MAPTALDH1A1HDAC3HDAC1HDAC7
SCHEMBL27995668 0.77 EGFR (0.60) ALDH1A1HDAC3HDAC1HDAC7HDAC8
SCHEMBL9832453 0.76 KDM4E (0.46) ALDH1A1HDAC3HDAC1HDAC7HDAC8
SCHEMBL2766900 0.76 HDAC3 (0.45) MAPTALDH1A1HDAC3HDAC1HDAC7
SCHEMBL2766904 0.76 HDAC3 (0.45) MAPTALDH1A1HDAC3HDAC1HDAC7
SCHEMBL4600962 0.75 ALDH1A1 (0.72) ALDH1A1HDAC3HDAC1HDAC7HDAC8
SCHEMBL18003043 0.74 MAPT (0.58) MAPTALDH1A1HTR2BKDM4EHPGD
SCHEMBL13815761 0.74 HTR2B (0.60) MAPTALDH1A1ERN1HTR2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104610230-A Compounds for the treatment of cancer UNIV TENNESSEE RES FOUNDATION 2015-05-13 CN disclosed
CN-102137592-B Compounds for the treatment of cancer UNIV TENNESSEE RES FOUNDATION (US) 2015-01-28 CN disclosed
EP-1400515-B1 CYCLIC DIAMINE COMPOUND HAVING FIVE-MEMBERED CYCLIC GROUP KOWA CO (JP) 2010-04-14 EP disclosed
EP-1400515-A1 CYCLIC DIAMINE COMPOUND HAVING FIVE-MEMBERED CYCLIC GROUP Kowa Co., Ltd. (JP) 2004-03-24 EP disclosed
US-6472386-B1 Cyclic diamine compound with 5-membered ring groups KOWA CO., LTD. (JP) 2002-10-29 US disclosed